ALLIANCE N0577

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Brain

Status:

Open

Phase III Intergroup Study of Temozolomide Alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy with Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma

Eligible for screening study DCP 001

MCC is a legacy NCCTG institution and site must offer patient participation in N0392 QOL study prior to randomization on N0577.  See N0392 protocol page for separate consent form and additional information.

NCT#00887146

Leave a Reply